The Crucial Role of 8-Fluoro-1,3,4,5-Tetrahydro-Azepino[5,4,3-cd]indol-6-one in Pharmaceutical Synthesis
Discover the essential pharmaceutical intermediate, 8-Fluoro-1,3,4,5-Tetrahydro-Azepino[5,4,3-cd]indol-6-one, vital for Rucaparib production. Learn about its properties, applications, and the expertise of its suppliers in China.
Get a Quote & SampleProduct Core Value
![8-Fluoro-1,3,4,5-Tetrahydro-Azepino[5,4,3-cd]indol-6-one](https://www.nbinno.com/webimg/gemini_6890b7d5b6b02_1754314709.png)
8-Fluoro-1,3,4,5-Tetrahydro-Azepino[5,4,3-cd]indol-6-one
As a leading supplier in China, we provide high-quality 8-Fluoro-1,3,4,5-Tetrahydro-Azepino[5,4,3-cd]indol-6-one, a critical intermediate for the synthesis of Rucaparib. Our commitment to purity and stringent quality control ensures that this compound meets the demanding requirements of pharmaceutical manufacturing. Its unique chemical structure makes it an indispensable building block for advanced therapeutic agents.
- Leveraging Rucaparib synthesis intermediate expertise, we ensure the highest standards for this vital pharmaceutical building block.
- Delivering high purity pharmaceutical intermediate, our product guarantees exceptional quality for your Rucaparib production needs.
- Exploring advanced organic synthesis building blocks, this compound is key for innovation in drug development.
- Sourcing crucial PARP inhibitor intermediate, we facilitate the production of life-saving cancer therapies.
Advantages Provided by the Product
Exceptional Purity
Our 8-Fluoro-1,3,4,5-Tetrahydro-Azepino[5,4,3-cd]indol-6-one boasts a minimum HPLC purity of 98.0%, essential for sensitive pharmaceutical applications and vital for reliable Rucaparib synthesis intermediate outcomes.
Controlled Moisture Content
With a moisture content of ≤1.0%, the compound maintains its stability and integrity, crucial for storage and handling in complex organic synthesis processes.
Strategic Intermediate Role
As a key building block for Rucaparib, this compound is instrumental in the development of PARP inhibitors, contributing significantly to advancements in cancer therapy.
Key Applications
Rucaparib Synthesis
This compound is a primary intermediate in the multi-step synthesis of Rucaparib, a vital PARP inhibitor used in oncology. Understanding Rucaparib synthesis intermediate pathways is crucial.
Pharmaceutical Research
Its fluorinated heterocyclic structure makes it a valuable building block for developing novel drug candidates and exploring new therapeutic avenues.
Organic Synthesis
Researchers in advanced organic synthesis utilize this compound for its unique reactivity and structural features, enabling complex molecular constructions.
API Manufacturing
As a high-quality API intermediate, it supports efficient and reliable manufacturing processes for active pharmaceutical ingredients, particularly for cancer treatments.